Case Studies >
Market Access

Patient Segmentation and Value Landscape Definition

image of pharmacy community engagement activities
Client Profile

Large Medtech

Key Stakeholders

Commercial, Medical Affairs, Market Access, and Program Management

Asset

Innovation Portfolio

Disease Area

Acute Care Dementia

Join Our Newsletter

Subscribe to our newsletter to receive the latest case studies.

Client Profile

Large Medtech

Key Stakeholders

Commercial, Medical Affairs, Market Access, and Program Management

Asset

Innovation Portfolio

Disease Area

Acute Care Dementia

Situation

The client was developing an innovation targeting a complex patient population.

Early planning was challenged by limited clarity on patient segmentation, care pathways, and value drivers relevant to payers and clinicians.

The client engaged Alkemi to generate actionable insights that could inform early product strategy and accelerate decision-making.

Approach

1. Conducted targeted literature reviews to assess patient outcomes, payer policies, reimbursement dynamics, and clinical data gaps.

2. Interviewed Key Opinion Leaders to refine patient segmentation, validate unmet needs, and assess population-specific epidemiology.

3. Synthesized findings into clear, decision-focused recommendations for cross-functional teams.

The focus throughout:

Create early clarity around who the product is for and how value should be framed.

Deliverables

1
Landscape assessment of secondary sources to define patient outcomes, value drivers, and payer coverage considerations.
2
Primary insights validating patient populations, use cases, and evidence requirements.
3
Patient segmentation and value framework to support early product strategy and planning.
4
5
6

Impact

"Thank you for such rich and valuable insights at the readout, especially on such a quick timeline!" - Associate Director of Innovation, Global Medical Affairs

Improved Market Understanding:

The client gained a comprehensive view of patient segmentation, journey, and value considerations.

Clear Evidence Priorities:

Insights highlighted key data gaps to inform future evidence generation planning.

Faster Strategic Decisions:

Early clarity supported confident product planning and accelerated the innovation timeline.

Experience The Alkemi Advantage Today